`Monday, August 13, 2018 7:35 PM
`Greg Gardella
`Natalie Grace; Ruth G Davila; Gardella Grace; NPisano@foley.com; Dara Del Rosario;
`CBolten@foley.com
`RE: Service Copy: IPR2018-00957 - Patent Owner Preliminary Response
`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Dear Greg:
`
`Petitioner ReShape Medical LLC intends to request a teleconference with the Board to seek guidance with respect to
`addressing Patent Owner’s allegations regarding the real‐party‐in‐interest in the above identified IPR and IPR2018‐
`00958. Are you available for a call tomorrow (Tuesday) after 11 am EST to briefly discuss Petitioner’s request and to
`provide us with your availability for a call with the Board?
`
`Best Regards,
`
`Chris
`
`Christopher C. Bolten
`
`Foley & Lardner LLP
`3579 Valley Centre Drive | Suite 300
`San Diego, CA 92130
`P 858.847.6887
`
`View My Bio
`Visit Foley.com
`
`From: Dara Del Rosario [mailto:ddelrosario@gardellagrace.com]
`Sent: Wednesday, August 08, 2018 5:15 PM
`To: Pisano, Nick; Bolten, Chris
`Cc: Greg Gardella; Natalie Grace; Ruth G Davila; Gardella Grace
`Subject: Service Copy: IPR2018-00957 - Patent Owner Preliminary Response
`
`Counsel,
`
`Please find attached, via the below Dropbox link, the service copy of the Patent Owner Preliminary Response along with
`Exhibits 2001‐2014 as filed today, August 8, 2018, in Case No. IPR2018‐00957. Please note that the link will expire in 30
`days.
`
`IPR2018‐00957 ‐ PO Preliminary Response ‐ Service Copy
`
`Sincerely,
`
`1
`
`Fulfillium Exhibit 2016, Page 1
`ReShape v. Fulfillium
`Case IPR2018-00958
`
`
`
`
`Dara Del Rosario | Senior Paralegal | Gardella Grace P.A.
`Main: 703‐556‐9600 | Direct: 703‐740‐4542 | ddelrosario@gardellagrace.com
`
`
`
`
`
`
`This email and any attachments may contain privileged or confidential information. Any unauthorized use or
`disclosure of this email is strictly prohibited. If you are not the intended recipient, please notify the sender by
`reply email, and delete this email and any attachments.
`
`
`The preceding email message may be confidential or protected by the attorney‐client or work‐product privileges. It is
`not intended for transmission to, or receipt by, any unauthorized persons. If you have received this message in error,
`please (i) do not read it, (ii) reply to the sender that you received the message in error, and (iii) erase or destroy the
`message and any attachments or copies. Any disclosure, copying, distribution or reliance on the contents of this
`message or its attachments is strictly prohibited, and may be unlawful. Unintended transmission does not constitute
`waiver of the attorney‐client privilege or any other privilege. Legal advice contained in the preceding message is solely
`for the benefit of the Foley & Lardner LLP client(s) represented by the Firm in the particular matter that is the subject of
`this message, and may not be relied upon by any other party. Unless expressly stated otherwise, nothing contained in
`this message should be construed as a digital or electronic signature, nor is it intended to reflect an intention to make an
`agreement by electronic means.
`This email and any attachments may contain privileged or confidential information. Any unauthorized use or disclosure
`of this email is strictly prohibited. If you are not the intended recipient, please notify the sender by reply email, and
`delete this email and any attachments.
`
`2
`
`Fulfillium Exhibit 2016, Page 2
`ReShape v. Fulfillium
`Case IPR2018-00958
`
`